These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24215342)

  • 1. Chromatin remodeling: a new landscape to treat harmful alcohol-use disorders.
    Warnault V; Ron D
    Future Med Chem; 2013 Nov; 5(17):2011-3. PubMed ID: 24215342
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromatin remodeling--a novel strategy to control excessive alcohol drinking.
    Warnault V; Darcq E; Levine A; Barak S; Ron D
    Transl Psychiatry; 2013 Feb; 3(2):e231. PubMed ID: 23423140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics: a link between addiction and social environment.
    Ajonijebu DC; Abboussi O; Russell VA; Mabandla MV; Daniels WMU
    Cell Mol Life Sci; 2017 Aug; 74(15):2735-2747. PubMed ID: 28255755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms of alcoholism and stress-related disorders.
    Palmisano M; Pandey SC
    Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
    Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
    Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and biology of chromatin remodeling agents: state of art and future perspectives of HDAC inhibitors.
    Rodriquez M; Aquino M; Bruno I; De Martino G; Taddei M; Gomez-Paloma L
    Curr Med Chem; 2006; 13(10):1119-39. PubMed ID: 16719774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Marek M; Shaik TB; Jung M; Sippl W; Pierce RJ; Romier C
    Biol Aujourdhui; 2016; 210(4):311-320. PubMed ID: 28327287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
    Bar-Sela G; Jacobs KM; Gius D
    Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain chromatin remodeling: a novel mechanism of alcoholism.
    Pandey SC; Ugale R; Zhang H; Tang L; Prakash A
    J Neurosci; 2008 Apr; 28(14):3729-37. PubMed ID: 18385331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin modifications (acetylation/ deacetylation/ methylation) as new targets for HIV therapy.
    Varier RA; Kundu TK
    Curr Pharm Des; 2006; 12(16):1975-93. PubMed ID: 16787242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching on epigenetic therapy.
    Karberg S
    Cell; 2009 Dec; 139(6):1029-31. PubMed ID: 20005793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.
    Schroeder FA; Penta KL; Matevossian A; Jones SR; Konradi C; Tapper AR; Akbarian S
    Neuropsychopharmacology; 2008 Nov; 33(12):2981-92. PubMed ID: 18288092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R; Ocker M
    IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted histone deacetylase inhibition for cancer prevention and therapy.
    Palmieri C; Coombes RC; Vigushin DM
    Prog Drug Res; 2005; 63():147-81. PubMed ID: 16265880
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
    Costa E; Grayson DR; Mitchell CP; Tremolizzo L; Veldic M; Guidotti A
    Crit Rev Neurobiol; 2003; 15(2):121-42. PubMed ID: 14977367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic surgery for lung cancer.
    Schrump DS
    J Surg Res; 2004 Mar; 117(1):107-13. PubMed ID: 15013720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
    Lugrin J; Ding XC; Le Roy D; Chanson AL; Sweep FC; Calandra T; Roger T
    Biochim Biophys Acta; 2009 Nov; 1793(11):1749-58. PubMed ID: 19747950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of chromatin remodeling agents for lung cancer therapy.
    Schrump DS; Hong JA; Nguyen DM
    Cancer J; 2007; 13(1):56-64. PubMed ID: 17464247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
    Lunke S; El-Osta A
    J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.